Premium
Mapping the platelet profile for functional genomic studies and demonstration of the effect size of the GP6 locus
Author(s) -
JONES C. I.,
GARNER S. F.,
ANGENENT W.,
BERNARD A.,
BERZUINI C.,
BURNS P.,
FARNDALE R. W.,
HOGWOOD J.,
RANKIN A.,
STEPHENS J. C.,
TOM B. D.,
WALTON J.,
DUDBRIDGE F.,
OUWEHAND W. H.,
GOODALL A. H.
Publication year - 2007
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2007.02632.x
Subject(s) - phenotype , platelet , platelet activation , locus (genetics) , genotyping , concordance , biology , immunology , computational biology , gene , genetics , medicine , genotype
Summary. Background: Evidence suggests the wide variation in platelet response within the population is genetically controlled. Unraveling the complex relationship between sequence variation and platelet phenotype requires accurate and reproducible measurement of platelet response. Objective: To develop a methodology suitable for measuring signaling pathway‐specific platelet phenotype, to use this to measure platelet response in a large cohort, and to demonstrate the effect size of sequence variation in a relevant model gene. Methods: Three established platelet assays were evaluated: mobilization of [Ca 2+ ] i , aggregometry and flow cytometry, each in response to adenosine 5′‐diphosphate (ADP) or the glycoprotein (GP) VI‐specific crosslinked collagen‐related peptide (CRP). Flow cytometric measurement of fibrinogen binding and P‐selectin expression in response to a single, intermediate dose of each agonist gave the best combination of reproducibility and inter‐individual variability and was used to measure the platelet response in 506 healthy volunteers. Pathway specificity was ensured by blocking the main subsidiary signaling pathways. Results: Individuals were identified who were hypo‐ or hyper‐responders for both pathways, or who had differential responses to the two agonists, or between outcomes. 89 individuals, retested three months later using the same methodology, showed high concordance between the two visits in all four assays ( r 2 = 0.872, 0.868, 0.766 and 0.549); all subjects retaining their phenotype at recall. The effect of sequence variation at the GP6 locus accounted for ∼35% of the variation in the CRP‐XL response. Conclusion: Genotyping‐phenotype association studies in a well‐characterized, large cohort provides a powerful strategy to measure the effect of sequence variation in genes regulating the platelet response.